What to Expect in Months 7-11 Essentially no side effects: Appetite suppression continues (desired effect), but GI symptoms gone Weight loss velocity slows: From 0.8kg/week (months 3-6) to 0.3-0.5kg/week Plateau around week 40-48: Weight stabilizes, no longer losing despite continued medication Total weight loss: Average 20-24% from baseline (matching or exceeding surgical outcomes) Focus shifts to maintenance: Accepting current weight, preventing regain Plateau frustration: Not a side effect but an emotional challenge 2 Final Strategies for Months 7-11 20
Summer Bodies Start with Science: Why GLP-1 Treatments Like Mounjaro and Ozempic Are in High Demand Jul 9, 2025 2 min read Summer is officially hereand that means long days, beach weekends, and plenty of reasons to feel confident in your own skin
It activates both GLP-1 and GIP receptors, while Wegovy and Ozempic focus solely on GLP-1, making Mounjaro a unique injection
Talk with your doctor about whether Vyvanse is right for you
Elevated levels of C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) are commonly found in Hashimoto's patients
At worst, they drain money on hype while exposing people to risks without providing any real medical benefit